Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00133068 · ClinicalTrials.gov registry record · Phase 4
Collaboration to Reduce Disparities in Hypertension
A Phase 4 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 4
- Development phase
- 802
- Enrollment target
NCT00133068: Completed Phase 4 study, sponsored by University of Pennsylvania.
NCT00133068 is a Phase 4 study that has completed, run by University of Pennsylvania. The registered enrollment target is 802 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00133068, a Phase 4 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 802 participants
- Enrollment target
Study Summary
A large number of African-American and low socioeconomic patients have poorly controlled high blood pressure because of not being able to take their high blood pressure medications. This puts these patients at higher risk of heart and kidney disease, stroke and death. This study is designed to reduce the barriers that prevent patients from taking their high blood pressure medications.
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Computer
- BEHAVIORAL Reduction in financial barrier
- BEHAVIORAL Computer intervention & reduction of financial barrier
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 802 participants |
| Start Date | 2005-03 |
| Est. Completion | 2008-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00133068
The ClinicalTrials.gov registry entry for NCT00133068 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 802 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Control is the first listed.
NCT00133068 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00133068 about?
NCT00133068 is a clinical study titled "Collaboration to Reduce Disparities in Hypertension". A large number of African-American and low socioeconomic patients have poorly controlled high blood pressure because of not being able to take their high blood pressure medications. This puts these patients at higher risk of heart and kidney disease, stroke and death. This study is designed to reduc...
What is the current status of trial NCT00133068?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 802 participants. The study started on 2005-03. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00133068?
The interventions under investigation include: Control (BEHAVIORAL), Computer (BEHAVIORAL), Reduction in financial barrier (BEHAVIORAL), Computer intervention & reduction of financial barrier (BEHAVIORAL).
Who is sponsoring clinical trial NCT00133068?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.